miR-31 promotes proliferation of colon cancer cells by targeting E2F2

Tong Li1, Wenjing Luo, Kunmei Liu

  • 1School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China, litong198824@163.com.

Biotechnology Letters
|November 3, 2014
PubMed

Insights

MicroRNA-31 (miR-31) promotes colon cancer growth by targeting E2F2. E2F2 suppresses tumors by regulating key cell cycle genes, offering a potential target for colon cancer drug design.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-31 (miR-31) is implicated in colon cancer progression.
  • The precise molecular mechanisms driving miR-31's role in colon cancer remain incompletely understood.

Purpose of the Study:

  • To investigate the functional role of miR-31 in colon cancer cell proliferation.
  • To elucidate the underlying molecular mechanism of miR-31 action in colon cancer.

Main Methods:

  • Identification of direct miR-31 targets using molecular biology techniques.
  • Assessment of miR-31's impact on colon cancer cell proliferation.
  • Analysis of E2F2's tumor suppressor functions and its regulation of downstream genes.

Main Results:

  • E2F2 was confirmed as a direct molecular target of miR-31.
  • miR-31 was shown to regulate colon cancer cell proliferation through its interaction with E2F2.
  • E2F2 demonstrated tumor suppressor activity by inhibiting survivin expression and modulating CCNA2, C-MYC, MCM4, and CDK2.

Conclusions:

  • miR-31 promotes colon cancer cell proliferation by targeting the tumor suppressor E2F2.
  • E2F2's regulation of cell cycle genes highlights its critical role in colon cancer.
  • These findings suggest that miR-31 represents a potential therapeutic target for colon cancer treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K